Vimta Labs Limited — Others, 18-06-2025: Amendment to AOA/MOA

Vimta Labs Limited has updated its Memorandum and Articles of Association, with the main change being the addition of Clause Nos. 7 and 8 to the Object Clause. These additions expand the company's activities to include Contract Research and Development (CDMO) in drug discovery, biotechnology, pharmaceuticals, and related fields, along with research and development of biologics, biosimilars, peptides, and complex generics including manufacturing and formulation development. The authorized share capital stands at Rs. 11.99 Cr, divided into equity shares of Rs. 2 each. The Articles detail governance, share capital management, Board powers, director appointment and rotation, dividend distribution, and other corporate procedures essential for shareholders and company operations.